
|Articles|November 20, 2007
George Koroneos
Advertisement
George Koroneos
News & Online Content Editor
George Koroneos oversees news content for Pharmaceutical Executive Magazine as well as two e-newsletters, Pharm Exec Direct and Pharm Exec Direct Marketing Edition. Prior to joining the team, George worked for Pharm Exec's sister publication
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




